- NEWS
- Update 24 August 2020
Evidence lags behind excitement over blood plasma as a coronavirus treatment
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 584, 505 (2020)
doi: https://doi.org/10.1038/d41586-020-02324-2
Updates & Corrections
-
Update 24 August 2020: The US Food and Drug Administration issued an emergency-use authorization on 23 August to treat COVID-19 with convalescent plasma.
References
Joyner, M. J. et al. J. Clin. Invest. https://doi.org/10.1172/JCI140200 (2020).
Joyner, M. J. et al. Preprint at medRxiv https://doi.org/10.1101/2020.08.12.20169359 (2020).
Joyner, M. J. et al. Preprint at medRxiv https://doi.org/10.1101/2020.07.29.20162917 (2020).
Landray, M. J. et al. Preprint at medRxiv https://doi.org/10.1101/2020.07.15.20151852 (2020).